Researchers have demonstrated that treating diabetic animals with alpha-1-antitrypsin following an islet transplantation procedure eliminates the inflammation that causes islet transplants to fail.
Researchers have demonstrated that treating diabetic animals with alpha-1-antitrypsin following an islet transplantation procedure eliminates the inflammation that causes islet transplants to fail.